F 0755
Level of Harm - Minimal harm
or potential for actual harm
Residents Affected - Few
Provide pharmaceutical services to meet the needs of each resident and employ or obtain the services of a
licensed pharmacist.
Based on interview and record review, the facility failed to ensure a licensed nurse documented on the
resident's Medication Administration Record (MAR - a daily documentation record used by a licensed nurse
to document medications and treatments given to a resident) after administering an antibiotic (medication
that kills or inhibits the growth of bacteria) for one of four sampled residents (Resident 1).This deficient
practice had the potential to result in medication errors and Resident 1 to receive duplicate medication
therapy, which could cause harm to the resident. During a review of Resident 1's admission Record, the
admission Record indicated that the facility admitted the resident on 4/21/2025 with diagnoses that
included hypokalemia (a condition where there is abnormally low level of potassium in the bloodstream),
rhabdomyolysis (a condition where damaged muscle tissue breaks down and releases its contents into the
bloodstream, potentially harming the kidneys ) and peripheral vascular disease (PVD- a slow progressive
narrowing of the blood flow to the arms and legs).During a review of Resident 1's Minimum Data Set (MDSa resident assessment tool) dated 5/1/2025, the MDS indicated that Resident 1 had mildly impaired
cognition (the mental action or process of acquiring knowledge and understanding through thought,
experience, and the senses) and was dependent on staff with toileting hygiene, shower or bathing,
dressing, personal hygiene, and mobility (movement).During a review of Resident 1's Physician Progress
Notes dated 4/23/2025, the Physician Progress Notes indicated Resident 1 can make needs known but can
not make medical decisions.During a review of Resident 1's Intravenous (IV- given directly into the blood
stream) MAR for 7/1/2025-7/31/2025, the IV MAR indicated Resident 1 had scheduled IV medication that
was due on 7/20/2025 at 9 p.m., which included:- Zosyn (antibiotic) intravenous solution 3-0.375 gram (gmunit of measurement)/50 milliliter (ml- unit of measurement) use 100 milliliters intravenously every 12
hours.Resident 1's IV MAR, dated 7/2025, indicated that the administration of Zosyn was left blank for
7/20/2025 for 9 p.m. There was no indication if Resident 1 received Zosyn or if Resident 1 refused the
medication.During an interview on 7/21/2025 at 3:45 p.m., with Registered Nurse 5 (RN 5), RN 5 stated
that he was the licensed nurse assigned to administer the IV Zosyn for Resident 1 during the evening shift,
3 p.m. to 11 p.m., on 7/20/2025. RN 5 stated that after he administered the IV medication to Resident 1, a
Certified Nursing Assistant asked for help to attend to a resident which made him forget to sign the IV MAR.
RN 5 stated he should sign the IV MAR right away so there is no question whether the resident received
the IV medication or not.During an interview on 7/21/2025 at 4:15 p.m., with the Director of Nursing (DON),
the DON stated that all licensed nurses should sign the IV MAR immediately after administering the IV
medication to ensure that the resident received their IV medication as scheduled or as prescribed.During a
review of the facility`s policy and procedure (P&P) titled, Preparation and General Guidelines Medication
Administration, last reviewed on 7/15/2025, the policy indicated medications are administered as prescribed
in accordance with good nursing principles and practices and only persons legally authorized to do so. The
individual who administers
(continued on next page)
Any deficiency statement ending with an asterisk (*) denotes a deficiency which the institution may be excused from correcting providing it is determined that other
safeguards provide sufficient protection to the patients. (See instructions.) Except for nursing homes, the findings stated above are disclosable 90 days following the
date of survey whether or not a plan of correction is provided. For nursing homes, the above findings and plans of correction are disclosable 14 days following the date
these documents are made available to the facility. If deficiencies are cited, an approved plan of correction is requisite to continued program participation.
LABORATORY DIRECTOR'S OR PROVIDER/SUPPLIER
REPRESENTATIVE'S SIGNATURE
TITLE
(X6) DATE
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Facility ID:
If continuation sheet
Page 1 of 2
Event ID:
056149
Printed: 05/15/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
056149
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
07/21/2025
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
California Healthcare and Rehabilitation Center
6700 Sepulveda Blvd.
Van Nuys, CA 91411
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0755
Level of Harm - Minimal harm
or potential for actual harm
the medication dose records the administration on the resident's MAR directly after the medication is given.
At the end of each medication pass, the person administering the medications reviews the MAR to ensure
necessary doses were administered and documented. In no case should the individual who administered
the medication report off-duty without first recording the administration of any medications.
Residents Affected - Few
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
056149
If continuation sheet
Page 2 of 2